Regarding FLT3, we subsequently performed a retrospective analysis of 1631 FLT3-ITD AML patients who underwent HSCT demonstrating the influence of cytogenetic risk category in transplanted FLT3-ITD AML patients. The gene discussed is FLT3; the disease is acute myeloid leukemia.